Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HelloMD is a leading digital healthcare platform specializing in telehealth services for patients seeking medical cannabis consultations and alternative wellness treatments. Founded in 2014, the company connects patients with licensed healthcare practitioners who provide medical recommendations and guidance on cannabis use for conditions such as chronic pain, anxiety, and sleep disorders. Beyond consultations, HelloMD offers an integrated marketplace and extensive educational resources to help consumers navigate the complexities of medical marijuana and CBD products. The company operates primarily in the United States and Canada, utilizing a proprietary technology stack to streamline the patient-to-practitioner experience. In 2022, HelloMD was acquired by Better Choice Company, a pet health and wellness enterprise, to expand its digital footprint in the broader health sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HelloMD.